TITLE

Protease inhibitors raising quality-of-life issues for HIV patients

AUTHOR(S)
Silversides, Ann
PUB. DATE
March 1999
SOURCE
CMAJ: Canadian Medical Association Journal;3/23/99, Vol. 160 Issue 6, p894
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Discusses the rising concern from AIDS activists and physicians who treat HIV/AIDS patients regarding body shape and metabolic changes associated with protease inhibitors. Efforts by Dr. David Cooper to develop a consensus case definition of the condition, which is referred to as lipodystrophy; Symptoms; Percentage of patients with lipodystrophy; Potential psychological impact; Comments from Paul MacPhee of AIDS Action Now!
ACCESSION #
1682164

 

Related Articles

  • World AIDS Day brings hope to those living with HIV/AIDS.  // Gay & Lesbian Times;11/25/2004, Issue 883, p12 

    Editorial. States that the World AIDS Day on December 1, 2004 will bring hope to people living with AIDS and HIV. AIDS Day's representation of progress in the treatment of AIDS, such as the development of AZT and combination drug therapy; Development of novel protease inhibitors that cause fewer...

  • Cocktail all in one. Kuhr, Fred // Advocate;1/17/2006, Issue 954, p44 

    The article addresses the problems associated with the use of the active antiretroviral therapy to treat HIV. By mid-1990s two new classes of anti-HIV drugs were introduced, one with protease inhibitors was introduced in December 1995 and other one with nonnucleoside reverse transcriptase...

  • HIV Protease Inhibitor--Related Lipodystrophy Syndrome. Carr, Andrew // Clinical Infectious Diseases;6/1/2000 Supplement 2, Vol. 30, pS135 

    Explores the association of HIV protease inhibitor (PI) therapy with lipodystrophy syndrome. Occurrence of peripheral lipoatrophy during the course of the therapy; Asymptomatic and nonketotic clinical presentation in diabetes associated with PI therapy; Abnormal lipodystrophy and metabolic...

  • Protease inhibitors may cause fat abnormalities and heart disease. Berger, Abi // BMJ: British Medical Journal (International Edition);07/11/98, Vol. 317 Issue 7151, p100 

    States that protease inhibitors are possible causes of the changes associated with body fat distribution and rising cholesterol concentration in persons infected with the human immunodeficiency virus (HIV). Description of the two protease inhibitors which are implicated in these metabolic...

  • Years of living dangerously. Brown, Phyllida // New Scientist;06/27/98, Vol. 158 Issue 2140, p20 

    Comments on the suspicion of HIV-positive patients that protease inhibitors are causing side effects. Positive aspects of protease inhibitors; Fat deposits on the body from the protease inhibitors; High levels of triglycerides in patients' blood, increasing the risk of heart attack; How...

  • Worth the weight.  // Advocate;02/03/98, Issue 752, p16 

    Discusses some unexpected side effects of AIDS drugs. Body changes brought by protease inhibitors drugs on AIDS patients; Other side effects of protease inhibitors; Several brands of protease inhibitors; Plan of Roxanne Laboratories Inc. for a clinical study of the medication's effect on methadone.

  • Caught in the act. Knight, Jonathan // New Scientist;05/27/2000, Vol. 166 Issue 2240, p18 

    Reports that researcher Mike Mueckler and colleagues have discovered the reason for side effects created by AIDS medication, such as redistribution of body fat and diabetes. Claim that the side effects could be permanently eradicated; Assertion that protease inhibitors cause the problems by...

  • AIDS DRUG 'COCKTAILS' LOSE THEIR PUNCH, MAY CAUSE HEART DISEASE.  // New Vegetarian & Natural Health;Spring2002, p63 

    Reports on growing evidence about adverse effects of cocktail drugs designed to combat AIDS. Possibility that the cocktail drugs provide higher rates of heart disease and cardiovascular deaths; Reported effects of protease-inhibitor drugs.

  • Combination Treatment for HIV.  // Combination Treatment for HIV;4/1/2004, p1 

    The article presents information about combination treatment for human immunodeficiency viruses (HIV). It enumerates the four main types of HIV drugs namely nucleoside analogues, non-nucleoside analogues, protease inhibitors and fusion inhibitors. It cites the side effects of combining these...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics